Motif Bio reports half-year 2017 financial results and operational progress

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 28 September, 2017 by The TZ Newswire Staff

Motif Bio reports half-year 2017 financial results and operational progress

NEW YORK, Sept. 29, 2017 (GLOBE NEWSWIRE) — Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical stage biopharmaceutical company specializing in developing novel antibiotics, today announced financial results for the half-year ended June 30, 2017.

See also
- Next Article Nikkei 225 closes down -0.03% at 20,356.28
- Previous Article UK Sept Nationwide HPI mm 0.2% vs 0.1% exp
Editorial Calender

September 2017

M T W T F S S

1 2 3

4 5 6 7 8 9 10

11 12 13 14 15 16 17

18 19 20 21 22 23 24

25 26 27 28 29 30

« Aug Oct »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 28 September, 2017 by The TZ Newswire Staff

Motif Bio reports half-year 2017 financial results and operational progress

See also

Editorial Calender

Recent Tags